Recently, another biomarkers, like the soluble fms-like tyrosine kinase 1 (sFlt-1), endoglin, PlGF, neurokinin-B have been used to try to predict the preeclampsia's onset and/or preeclampsia's complications (15–20). This evidence concerns the gene FLT1 and preeclampsia.